YANG Wenbo,ZHANG Na&rsquo,an,et al.Etiological identification and biological characteristics of recurrent melioidosis: report of 1 case[J].J Amry Med Univ (J Third Mil Med Univ),2021,43(22):2441-2448.

1例复发类鼻疽的病原学鉴定及生物学特性研究(/HTML )




Etiological identification and biological characteristics of recurrent melioidosis: report of 1 case
YANG Wenbo ZHANG Na’an RAO Chenglong XIA Yupei ZHANG Meijuan LI Xiao YAN Jingmin CHEN Hai LI Qian MAO Xuhu

Department of Clinical Microbiology and Immunology, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University), Chongqing, 400038; 2College of Life Science and Technology Huazhong Agricultural University, Wuhan, Hubei Province, 430070; 3Department of Clinical Laboratory Sanya People’s Hospital, Sanya, Hainan Province, 572000, China

Burkholderia pseudomallei recurrence whole genome differential protein
R372; R378.99; R515.9

目的通过对1例复发类鼻疽进行系统病原学鉴定及生物学特性研究,分析和探讨类鼻疽菌长期滞留机体可能的适应宿主机制。方法对临床收集的来源于同一个患者时隔5年分离到的两株类鼻疽菌,进行微生物学鉴定、全基因组测序,并使用相关软件对测序数据进行多位点序列分型(multilocus sequence typing,MLST)、同源比对进化树、单核苷酸多态性(single nucleotide polymorphism,SNP)以及插入缺失(insertion-deletion,Indel)分析;进一步在感染肺上皮A549细胞模型中比较感染不同时间细胞内细菌载量变化;双向电泳-质谱技术分析两株细菌在蛋白水平的表达变化。结果分离到的两株类鼻疽菌,全基因组均约7.12 Mb,COG功能注释编码蛋白大致约5 000个;MLST分型均为ST58型;同源比对进化树分析显示它们位于同一分支且与其他分离自中国的类鼻疽菌亲缘关系较近;SNP/Indel分析显示复发株有114个SNP位点、55个Indel位点;与原发株相比,双向电泳-质谱结果表明复发株共有68个蛋白的表达水平发生了显著的变化;同时复发株感染A549后细胞内细菌载量明显增加(P<0.05)。结论以上复发菌株的基因组学、蛋白组学以及胞内感染增殖能力的系统研究提示类鼻疽菌可能在机体长期的选择压力下微进化,通过对细菌基因转录表达、分泌系统、耐药以及能量代谢等方面的调控更加适应其在宿主体内的生存而实现长期滞留。


ObjectiveTo analyze and explore the possible adaptive mechanisms that Burkholderia pseudomallei (B. pseudomallei) could long-term reside in the host cells based on the systematic etiological identification and biological characteristics of a patient with recurrent melioidosis. MethodsThe 2 B. pseudomallei strains isolated from the same patient at an interval of 5 years were performed for microbiological identification and genome sequencing, and the sequencing data were further analyzed by multilocus sequence typing (MLST), phylogenetic tree analysis of homologous alignment, single nucleotide polymorphism (SNP) analysis and insertion-deletion (Indel) analysis, respectively. Furthermore, the intracellular survival of the 2 clinical isolates of B. pseudomallei were examined at different times by counting the viable bacteria in the A549 cells. Two-dimensional electrophoresis (2-DE) and mass spectrometry was employed to analyze the protein expression of 2 strains of bacteria. ResultsThe 2 clinical isolates had a whole genome of about 7.12 Mb, and up about 5 000 Clusters of Orthologous Groups (COG) annotations, and was identified as sequence type (ST) 58 by MLST analysis. Phylogenetic analysis of homologous alignment showed that they were located in the same branch and were closely related to other B. pseudomallei isolates from China. SNP/Indel analysis indicated that there were 114 SNP sites and 55 Indel sites in the recurrent strain. The results of 2-DE displayed that the expression levels of 68 proteins in the recurrent strain were significantly changed compared with the primary strain. The intracellular bacterial load of recurrent strain was significantly increased compared to the primary strain in A549 cells(P<0.05). ConclusionBased on a series of studies with genomics, proteomics and ability of intracellular survival of the 2 clinical isolates of B. pseudomallei, the bacterium may evolve slightly under the long-term selective pressure of the organism, and adapt to the host environment for its own survival through the regulation of bacterial transcription, secretion system, drug resistance and energy metabolism.


[1]LIMMATHUROTSAKUL D, GOLDING N, DANCE D A B, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis[J]. Nat Microbiol, 2016, 1(1): 1-13. DOI: 10.1038/nmicrobiol.2015.8.
[2]WIERSINGA W J, VIRK H S, TORRES A G, et al. Limmathurotsakul D:  Melioidosis[J]. Nat Rev Dis Primers, 2018, 4: 17107. DOI:10.1038/nrdp.2017.107.
[3]PEACOCK SJ. Melioidosis[J]. Curr Opin Infect Dis, 2006, 19(5): 421-428.DOI:  10.1097/01.qco.0000244046.31135.b3.
[4]SCHMIDT I H E, GILDHORN C, BNING M A L, et al. Burkholderia pseudomallei modulates host iron homeostasis to facilitate iron availability and intracellular survival[J]. PLoS Negl Trop Dis 2018, 12(1): e0006096. DOI: 10.1371/journal.pntd.0006096.
[5]RUSTAD T R, HARRELL M I, LIAO R, et al. The enduring hypoxic response of Mycobacterium tuberculosis[J]. PLoS ONE 2008, 3(1): e1502. DOI: 10.1371/journal.pone.0001502.
[6]ALLWOOD E M, DEVENISH R J, PRESCOTT M, et al. Strategies for intracellular survival of Burkholderia pseudomallei[J]. Front Microbiol, 2011, 2: 170.
[7]VANDER BROEK C W, STEVENS J M.TYPE Ⅲ secretion in the melioidosis pathogen Burkholderia pseudomallei[J]. Front Cell Infect Microbiol, 2017, 7: 255. DOI:10.3389/fcimb.2017.00255.
[8]MUANGSOMBUT V, SUPARAK S, PUMIRAT P, et al.Inactivation of Burkholderia pseudomallei bsaQ results in decreased invasion efficiency and delayed escape of bacteria from endocytic vesicles[J]. Arch Microbiol 2008, 190(6): 623-631. DOI:10.1007/s00203-008-0413-3.
[9]BURTNICK M N, BRETT P J, NAIR V, et al. Burkholderia pseudomallei type Ⅲ secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages[J]. Infect Immun 2008, 76(7): 2991-3000. DOI:10.1128/IAI.00263-08.
[10]PILATZ S, BREITBACH K, HEIN N, et al. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence[J]. Infect Immun, 2006, 74(6):  3576-3586. DOI: 10.1128/iai.01262-05.
[11]KANG W T, VELLASAMY K M, CHUA E G, et al. Functional characterizations of effector protein BipC, a type Ⅲ secretion system protein, in Burkholderia pseudomallei pathogenesis[J]. J Infect Dis, 2015, 211(5): 827-834. DOI:10.1093/infdis/jiu492.
[12]SRINON V, MUANGMAN S, IMYAEM N, et al. Comparative assessment of the intracellular survival of the Burkholderia pseudomallei bopC mutant[J]. J Microbiol, 2013, 51(4):  522-526. DOI: 10.1007/s12275-013-2557-3.
[13]AUNKHAM A, SCHULTE A, WINTERHALTER M, et al.Porin involvement in cephalosporin and carbapenem resistance of Burkholderia pseudomallei[J]. PLoS ONE, 2014, 9(5): e95918. DOI:10.1371/journal.pone.0095918.
[14]RHOLL DA, PAPP-WALLACE KM, TOMARAS AP, et al. Molecular investigations of PenA-mediated beta-lactam resistance in Burkholderia pseudomallei[J]. Front Microbiol, 2011, 2: 139. DOI:10.3389/fmicb.2011.00139.
[15]PODNECKY N L, WUTHIEKANUN V, PEACOCK S J, et al. The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates[J]. Antimicrob Agents Chemother, 2013, 57(9):  4381-4386. DOI: 10.1128/aac.00660-13.
[16]CHANTRATITA N, RHOLL DA, SIM B, et al. Anti-microbial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei[J]. Proc Natl Acad Sci USA, 2011, 108(41): 17165-17170. DOI:10.2307/41321850.
[17]HAMAD MA, AUSTIN CR, STEWART AL, et al. Adaptation and antibiotic tolerance of anaerobic Burkholderia pseudomallei[J]. Antimicrob Agents Chemother, 2011, 55(7): 3313-3323. DOI:10.1128/AAC.00953-10.


 Su Yi,Lai Sihan,Yi Hai,et al.Allogeneic hematopoietic stem cell transplantation for recurrent lymphoma after autologous stem cell transplantation: clinical analysis of 17 cases[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(22):2456.
 TANG Peng,JIANG Jun,YANG Xin-hua,et al.Clinical and pathological influencing factors for breast cancer recurrence and metastasis after mastectomy[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(22):1099.
 WANG Hong-bo,YEERJIANG·Dahaer,JIN Ge-le,et al.Risk factors of postoperative recurrence of spinal tuberculosis: a comparative analysis on 486 cases[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(22):1955.
 Wang Ying,Chen Ren&rsquo,an,et al.Efficacy of micro transplantation induction combined with chemotherapy for refractory and relapsed acute myeloid leukemia[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(22):1347.
 Xu Lei,Pan Yongquan,He Mingzhong,et al.Induction and features of relapsing experimental autoimmune uveoretinitis in mice[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(22):1432.
 Yuan Jing,Zhang Changjiang,Zhu Yan,et al.Clinical outcome and impact factors of HBV-related patients’ relapse after nucleoside/nucleotide analogues withdrawal[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(22):811.
[10]郭华阳,周来新,刘斌,等.复发尖锐湿疣中人乳头瘤病毒基因的原位杂交法分型观察[J].陆军军医大学学报(原第三军医大学学报),1996,18(01):0.[doi:10.16016/j.1000-5404.1996.01.014 ]
 Guo Huayang,Zhou Laixin,Liu Bin,et al.[J].J Amry Med Univ (J Third Mil Med Univ),1996,18(22):0.[doi:10.16016/j.1000-5404.1996.01.014 ]

更新日期/Last Update: 2021-11-23